Kellie McLain
Nurse Practitioner · Charleston, SCNPI 1811005788
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Esperion Therapeutics, Inc. accounts for 84.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $12,304 and has fallen 93.2% since, to $840 in 2025. Among nurse practitioner clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $404.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Esperion Therapeutics, Inc.$24K
- Regeneron Healthcare Solutions, Inc.$3K
- Novartis$688
- Cvrx, Inc.$167
- Boston Scientific$149
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$96
- plus $126 from 3 others
What the payments were for
- Consulting fees$3,12311%
- Speaking & faculty fees$16,83059%
- Travel & lodging$6,32722%
- Food & beverage$2,0617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Esperion Therapeutics, Inc. | 40 | $24,072 |
| Regeneron Healthcare Solutions, Inc. | 16 | $3,043 |
| Novartis | 1 | $688 |
| Cvrx, Inc. | 5 | $167 |
| Boston Scientific | 2 | $149 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $96 |
| Amgen | 2 | $63 |
| Boehringer Ingelheim | 1 | $33 |
| AstraZeneca | 2 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$28,340 in reported general payments places this provider in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 787 | $995,572 |
| Praluent PenAlirocumab | 249 | $286,462 |
| NexletolBempedoic Acid | 47 | $44,383 |
| NexlizetBempedoic Acid/Ezetimibe | 31 | $16,654 |
| EliquisApixaban | 12 | $13,021 |
| Ezetimibe | 302 | $7,313 |
| Rosuvastatin Calcium | 349 | $4,832 |
| Pitavastatin Calcium | 13 | $2,715 |
| Icosapent Ethyl | 14 | $2,073 |
| Atorvastatin Calcium | 141 | $1,525 |
| Metoprolol Succinate | 86 | $1,309 |
| Lisinopril | 49 | $503 |
| Losartan Potassium | 44 | $472 |
| Pravastatin Sodium | 43 | $424 |
| Chlorthalidone | 31 | $392 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Esperion Therapeutics, Inc.Nexletol, Nexlizet | $24,072 | $61,03778 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,346 nurse practitioner providers in South Carolina.
Other nurse practitioner in Charleston
- Whitney ReedCharleston$54K
- Mary JohnsonCharleston$34K
- Amanda HareCharleston$30K
- Kristen LaudatiCharleston$15K
- Alice MazzellaCharleston$12K
- Samantha PecunesCharleston$12K
- Christine BrusmanCharleston$12K
- Shanda HofmannCharleston$11K
- Diane BurdsalCharleston$10K
- Kendall BowlerCharleston$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.